Research funding during the COVID-19 pandemic

Research funding-bodies around the world are now mobilising in the fight against the new coronavirus. Grants Office at KI will continously keep you updated on new grant announcements and changed terms in ongoing funding as a result of the COVID-19 pandemic.

New Funding opportunitues

Swedish funding

The Swedish Research Council - New calls in virus research

Career support funding for research into virus and virus-caused disease conditions
The calls for international postdoc grant, starting grant and consolidation grant are aimed at researchers at the beginning of their careers. The three calls have a joint focus on research into virus and disease conditions caused by viruses.

Closing date: 25 August 2020

Project grant for research collaboration between South Korea and Sweden

This call makes it possible for researchers in Sweden to collaborate with researchers in South Korea on questions relating to COVID-19.

Closing date: 25 August 2020

More information about the calls
 

COVID-19 Global South Artificial Intelligence (AI) and Data Innovation Fund - Sida and IDRC

Sida and the International Development Research Centre (IDRC) and Sida are planning to launch a COVID-19 Global South Artificial Intelligence (AI) and Data Innovation Fund to support AI and data-enabled innovations that can directly assist low-and middle-income countries in responding to, recovering from, and building resilience during the current COVID-19 crisis, and for other potential pandemics. The fund aims to build local capacity and leadership in the global south to leverage data science and AI in strengthening pandemic-responsive public health systems.

The fund will include a closed call for proposals, with short time for proposal preparation and rapid review and decision process, and your organisation will be among the organisations invited to apply. Preference will be given to consortia of actors, and consortia may include partners in the Global North.

Scope and focus of the call
 

Innovation projects in the health field that dampen the prevalence and effects of the covid-19 pandemic

Health-related innovation projects and feasibility studies are funded within the call for proposal. These should help to curb the spread and effects of the covid-19 pandemic and prevent future pandemics. The results of the innovation projects should be implemented and utilized already during the ongoing pandemic, and the results of the feasibility studies will lead to increased preparedness for future pandemics.

Closing date: 18 August 2020

More information
 

Pre-studies for innovation projects in the health area that prevent future pandemics

Health-related innovation projects and feasibility studies are funded within the call for proposal. These should help to curb the spread and effects of the covid-19 pandemic and prevent future pandemics. The results of the innovation projects should be implemented and utilized already during the ongoing pandemic and the results of the feasibility studies should lead to increased preparedness for future pandemics.

Closing date: 18 August 2020

More information
 

FORMAS - Societal effects and opportunities for transition after Covid-19

This call is a joint initiative by Formas and the Swedish Civil Contingencies Agency (MSB) within the framework of Formas’ three national research programmes on climate, food and sustainable spatial planning, as well as MSB’s responsibility for research within civil protection and preparedness. The call will help increase our understanding of the impacts of Covid-19 and the opportunities for transformation and recovery in the face of crises.

Closing date: 3 September 2020

More information
 

AFA Försäkring (AFA Insurance) – Project grants

How is COVID-19 affecting work life, work environment and health, management of working environment and the conditions for leadership.

Closing date: 1 October 2020

Information and submission

Funding from the EU

EIT Health - Addressing pandemics

In light of the global pandemic of COVID-19, a new category of submissions is being solicited to address one or more topics related to prevention and management of the current, as well as potential future, pandemics. Therefore, submissions are also welcome that address one or more topics related to the prevention and management of the current, as well as potential future, pandemics:

  • Hinder disease spread and prevention of outbreaks
  • Optimise screening and diagnosis
  • Treat people better
  • Healthcare organisation's resource management, logistics and supply chains
  • Data-driven initiatives

Closing date Expressions of Interest on the topic of pandemics: 27 May 2020

Closing date Full Proposal: 8 July 2020

KI EIT Health webpage

EIT Health Scandinavia - BP2021 Call page
 

COVID-19 outbreak: latest updates on H2020 call deadlines

Reacting to the Covid-19 crisis, deadlines for some calls are extended to give more time for applicants to prepare their proposals. 

Latest H2020 calls deadlines updates
 

Extraordinary Call for Proposals for Access Projects related to the COVID-19 crisis

EASI-Genomics is a European Genomics Infrastructure Horizon 2020 project, which started on 1st February 2019. This novel infrastructure supports researchers in next-generation sequencing and other high-end genomics applications and genomic data analysis. The infrastructure is accessible to academic researchers, research groups and scientific institutions, as well as industry, including SMEs.

In light of the current Covid-19 crisis, EASI-Genomics is taking the measure to issue an extraordinary call. EASI-Genomics invites external users to apply for access with proposals related to the COVID-19 epidemic for a total budget of 0.5 million €. 

Extraordinary Call for Proposals for Access Projects related to the COVID-19 crisis
 

Call for collaboration for access to screening facilities for rationally selected compounds against SARS-CoV-2

Exscalate4CoV (acronym E4C) is an EU-funded project that was selected after the emergency Call of expression of interest that the European Commission (DG RTD) issued on 31 January. The E4C project is establishing a pipeline of phenotypic and target based screens to evaluate the efficacy of repurposed, commercial and de-novo designed compounds. To supplement the E4C compound pipeline, they invite organisations to submit proposals for screening of their compounds for efficacy profiling on the E4C Biology platforms.

Information and Submission  

Funding from the US & the rest of the world

NIH Calls for SARS-CoV-2/COVID-19

National Institute of Allergy and Infectious Diseases (NIAID) is issuing this Notice of Special Interest (NOSI: NOT-AI-20-031) to highlight the need for research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19). NIAID is particularly interested in projects focusing on viral natural history, pathogenicity, transmission, as well as projects developing medical countermeasures and suitable animal models for pre-clinical testing of vaccines and therapeutics against SARS-CoV-2/COVID-19.

Submit applications for this initiative using one of the following funding opportunity announcements (FOAs) or any reissues of these announcement through the expiration date of this notice (April 5, 2021):

  • PA-19-052 NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed)
    • First deadline on June 16, 2020 until Feb 16, 2021.
    • This R03 budgets are limited to $50,000 in direct costs per year and max 2 years.
       
  • PA-19-053 - NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed)
    • First deadline on June 16, 2020 until Feb 16, 2021.
    • This R21 budgets are limited to $ $275,000 in direct costs per year and max 2 years.
       
  • PA-19-056 NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)
    • First deadline on June 5, 2020 until Feb 5, 2021.
    • Application budgets are not limited but need to reflect the actual needs of the proposed project. Maximum duration of the project is 5 years.
       
  • PAR-20-177 Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R21 Clinical Trial Not Allowed)
    • Deadline: Applications will be accepted on a rolling basis, beginning on 04/30/2020 until April 30, 2021.
       
  • PAR-20-178 Emergency Awards: Rapid Investigation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (R01 Clinical Trial Not Allowed)
    • Deadline: Applications will be accepted on a rolling basis, beginning on 04/30/2020 until April 30, 2021.

Further info on the NIH calls
 

US Army Medical Research Acquisition Activity (USAMRAA)

USAMRAA is publishing information on flexibilities for organizations funded by USAMRAA to conduct research on COVID-19 along with Frequently Asked Questions (FAQs) on other administrative flexibilities whose operations have been adversely impacted in the emergency response related to COVID-19. These FAQs will be updated as more information becomes available.

US Army Medical Research Acquisition Activity (USAMRAA) 

USAMRAA Response to the COVID-2019 Outbreak
 

Gates Foundation-Response to Covid-19

The Therapeutics Accelerator is an initiative launched by the Bill & Melinda Gates Foundation, Wellcome, and Mastercard to speed-up the response to the COVID-19 epidemic by identifying, assessing, developing, and scaling up treatments. The partners are committed to equitable access, including making products available and affordable in low-resource settings. The COVID-19 Therapeutics Accelerator will play a catalytic role by accelerating and evaluating new and repurposed drugs and biologics to treat patients with COVID-19 in the immediate term, and other viral pathogens in the longer-term.

About the COVID-19 Therapeutics Accelerator

COVID-19 Updates from the Gates Foundation
 

Call for code global challenge from IBM Corporation, US

Cause, invites submissions for its call for code global challenge. This recognises practical and sustainable open source solutions to mitigate the impact of COVID-19 and climate change. Teams of up to five developers, data scientists, designers, business analysts or entrepreneurs may apply.

The overall winner receives a USD 200,000 cash prize as well as opportunities for mentorship and networking, and solution and implementation support. The first and second runners up receive a USD 25,000 cash prize while the third and fourth runners up receive a USD 10,000 cash prize. The grand prize winner and the first and second runners up receive travel support to attend the award announcement ceremony and all five prize winners receive open source project support from the Linux Foundation.

Deadline: July 31, 2020.

Call for code global challenge from IBM Corporation, US
 

Chan Zuckerberg Initiative – Response to Covid-19

The work of CZI’s team is aimed at leveraging open science, technology, and collaboration to accelerate our shared understanding of COVID-19.

Chan Zuckerberg Initiative – Response to Covid-19
 

Islamic Development Bank (IsDB) Group

Call for proposals for innovation around preparedness and response to COVID-19 with deadline on June 1, 2020.
 

Elevate Prize Foundation

The Elevate Prize Foundation is accepting entries for the inaugural Elevate Prize, which will give 10 awards, each worth at least $300,000 over two years, to organizations successfully making positive, transformational change in the world. This includes solutions that can help communities around the world prepare for, detect, and respond to emerging pandemics and health-security threats, including the novel coronavirus. Entries are due June 29, 2020.

Changed Terms for Ongoing Funding

Swedish funding

Here is information from some of our biggest funders on how ongoing grants might be affected by the ongoing COVID-19 pandemic. Please look at respective homepage for updates news. For other funders, please contact them directly for information.
 

The Swedish Research Council

The Swedish Research Council could grant an extension to the availability period of research projects at risk of being delayed due to COVID-19. If a research project is at risk of being significantly delayed due to COVID-19 and cannot be completed within the availability period, they may grant an extension to the availability period.

Deadline for financial and scientific reporting is extended to 30 April. As a result of the current COVID-19 situation, the Swedish Research Council has now extended the deadline for financial and scientific reporting of grants. If you were due to submit a report by 31 March, you now have one extra month to do so.

More information
 

Vinnova

Vinnova has published the following information regarding ongoing projects.
If the coordinated partner in your project is unable to report the project's costs due to, for example, layoffs, you can contact your project officer and ask to change the coordinator temporarily. This can happen, for example, in projects where some parties are active and have costs, but other parties cannot work because they have been laid off.

In order to extend projects to be able to complete your project in the best way, you need to request a change in project time. If you want to pause the project and then restart the project when the situation has changed, you request a change of project time.

If you need to re-distribute your budget substantially in order to carry out the project, you need to request a change in the budget. You do this by requesting a change in your project. Vinnova understands that extra costs may arise in connection with the cancellation of trips and meetings. Therefore, they have made it clear what costs they can finance.

More information
 

Forte

Extension of the project duration. If you have an ongoing grant from Forte, you are expected to carry out your project within the original timeframe. However, there are circumstances when it is possible to extend the availability period of the grant. If an extension is needed, you make a request in Prisma according to Forte’s normal procedures. However, you should not do this until the extent of the delay is known.

Reporting. Researchers and economists that are responsible for the reporting of ongoing grants are expected to submit the required reports within the original timeframe. If any obstacles arise, please contact Forte at forte@forte.se , or contact the person at Forte that is responsible for the call in which your grant was awarded.

More information
 

Formas

Formas will extend the perios for economic and scientfic reporting for all projects with original reporting period 29 February - 30 May. New deadline for reporting is May 31.

Forte has an understanding that the corona situation can affect the circumstances in ongoing projects. They are now reviewing the ways we can extend the availability period and what decision support Formas needs in order to decide on changes and extensions of a project’s implementation.

More information
 

Heart-Lung Foundation

Opportunity to change research focus - The Heart Lung Foundation now enables researchers who have ongoing research support from the Heart Lung Foundation to use these funds for research on how covid-19 affects patients with chronic cardiovascular disease and lung disease. If you wish to change the focus of the project, the research department at the Hjärt-Lungfonden must be informed of this via e-mail

Current information on the payment of research grants. When you request your research grant from the Heart- Lung Foundation they ask you to scan the completed and signed form and then e-mail it to ekonomi@hjart-lungfonden.se For a period they will have limited opportunities to receive requisition forms per mail. If you have sent a requisition form by mail to the Heart-Lung Foundation after March 10, please send it again by e-mail as above.

More information
 

SSMF

If, as a grant recipient, you are in need of postponing your project start or if need to pause the ongoing grant period due to the Corona pandemic, please notify SSMF so that we can extend your time available. For those who have ongoing postdoctoral fellowships, SSMF offers, in addition to extended disposition time, the opportunity to apply for an extended grant of up to two months. This applies if the prevailing circumstances have seriously affected the possibility of conducting research projects as planned.

More information

Funding from the EU

Some of the most frequently asked questions regarding ongoing H2020 projects can be found below. If you have questions regarding your specific EU:project, please contact KI Grants Management Office.

All H2020-FAQ related to the COVID-19 outbreak
 

Marie Skłodowska Curie Actions

MSCA fellows and support staff have the possibility to invoke the “force majeure” clauses which the Research Executive Agency Project Officers will assess case-by-case. KI Grants Management Office can help you with this. 

For updates regarding project implementation and Mobility within MSCA, see the Corona Virus: Consequences for Marie Skłodowska-Curie Actions (MSCA) projects and related activities 

Funding from the US

Coronavirus Disease 2019 (COVID-19): Information for NIH Applicants and Recipients of NIH Funding

NIH provide updated guidance, information, and FAQs as they become available.

Coronavirus Disease 2019 (COVID-19): Information for NIH Applicants and Recipients of NIH Funding
 

Flexibilities Available to Applicants and Recipients of Federal Financial Assistance Affected by COVID-19

The purpose of this Notice (NOT-OD-20-086) is to alert the community of administrative flexibilities that will apply to NIH applicants and recipients. Therefore, NIH has identified the following short-term administrative flexibilities to assist our applicants with managing administrative, financial management and audit requirements under the Uniform Guidance “Uniform Administrative Requirements.
 

Pre-Award Costs

NIH is allowing pre-award costs to be incurred from January 20, 2020 through the public health emergency period and prior to the date of a federal award for all applicants and recipients that have been affected by COVID-19.
 

Extension of Post-Award Financial and Other Reporting

If your institution is unable to complete and submit financial and Research Progress Performance Reports (RPPR) by the scheduled due date, due to the effects of COVID-19, please be sure to contact the assigned grants management and/or program official to let them know the reports will be late.

NIH will accept these late reports but will delay issuing grant awards until the reports are received and accepted by the appropriate Institute or Center (IC).

Flexibilities Available to Applicants and Recipients of Federal Financial Assistance Affected by COVID-19
 

Guidance for NIH-funded Clinical Trials and Human Subjects Studies Affected by COVID-19

NIH recognizes the significant effects that this emergency is having on NIH-funded clinical trials and other human subjects studies.

Guidance for NIH-funded Clinical Trials and Human Subjects Studies Affected by COVID-19

 

Contact us